Navigation Links
Emerging importance of computerized cognitive testing -- new therapies for dementia
Date:7/18/2013

Boston, MA Computerized cognitive testing is increasingly playing a key role in therapy development for dementia and Alzheimer's disease. This week at the Alzheimer's Association International Conference, Keith Wesnes Ph.D., Practice Leader of Bracket and founder of the CDR System, discussed new data for novel therapies at two poster presentations at the Alzheimer's Association International Conference.

Poster Title: Cognitive evidence in Alzheimer's disease patients that compromised hippocampal neurogenesis is related both to APOE4 status and CSF Abeta42

This presentation provides the first behavioural data in Alzheimer's patients which associates genetic and biomarker activity to dysfunction in a major brain area involved both in memory and the production of new nerve cells (neurogenesis), This exciting finding obtained in collaboration with a group including Kaj Blennow, University of Gothenburg, found that patients with two APOE ϵ4 alleles (which confer a 10 to 30 fold increased risk of developing Alzheimer's disease) showed a selective decline in a computerised cognitive test measure associated with activity in the hippocampal dentate gyrus. Furthermore, in all patients studied, this test measure was more closely associated with the levels of the Aβ42 biomarker for the disease than a number of other memory measures associated with different hippocampal regions.

As interest in Alzheimer's research is shifting to begin treating the disease at its earliest stages, these findings identify a potential genetic and biomarker strategy for selecting individuals for early treatment with therapies which may promote hippocampal neurogenesis.

Poster Title: Memantine improves attention and verbal episodic memory in Parkinson's disease dementia and dementia with Lewy bodies: a double-blind placebo-controlled multicentre trial

A second presentation provides the first data that performance on objective tests of attention and memory can be improved by memantine in two other major forms of dementia - Parkinson's disease dementia and dementia with Lewy Bodies. The improvements detected were highly statistically reliable and of clinically relevant effect sizes; indicating that memantine can produce cognitive benefits in patients with these dementias which match those seen previously with anticholinesterases.

Both studies utilised the CDR System, an automated cognitive test system, making a strong case for benefits for the increased sensitivity and specificity that such procedures bring to dementia research, when compared with the traditional tests which have been historically employed.

Another recent Alzheimer's trial conducted by Orion Corporation demonstrated proof of concept of a new drug with a novel mode of action. The phase II clinical trial tested ORM-12741 -- the first drug to target a specific subtype of adrenergic receptors (alpha-2c) in the brain, which are believed to be involved in modulation of brain functions under stressful conditions. The trial of 100 patients showed significant positive effects on episodic memory in patients with moderate Alzheimer's disease. Efficacy was assessed using the CDR System.


'/>"/>

Contact: Annette Larkin
larkinannette@yahoo.com
703-772-6427
Bracket Global
Source:Eurekalert

Related biology news :

1. UF researchers look for ways to make an emerging technology safe for environment
2. Updates in Interventional Radiology accents emerging trends, practice growth
3. DNA Sequencing: Emerging Technologies and Applications
4. Malaysia to battle nutrition transition problem emerging worldwide: More income, poorer diet choices
5. Scientists question the designation of some emerging diseases
6. Emerging virus in raccoons may provide cancer clues
7. Nanoparticle researcher will inaugurate prestigious emerging leaders lecture series
8. Press registration open for ASM Biodefense and Emerging Diseases Research Meeting
9. Young malaria parasites refuse to take their medicine, may explain emerging drug resistance
10. Watering the forest for the trees emerging as priority for forest management
11. EU-funded study underlines importance of Congo Basin for global climate and biodiversity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2018)... ... , ... Inthirani Arul, an evidence-based healer, today announces research results based on ... disorders. , Biomarkers for immune function, blood, as well as, inflammation, were assessed ... increase in overall immunity as seen by the rise in antibody levels , ...
(Date:7/26/2018)... (PRWEB) , ... July 25, 2018 , ... ... meeting for C-level biopharma executives on September 4, 2018 at The Hilton Boston ... leverage insight from real-life business development experiences and dissect the most relevant deals ...
(Date:7/26/2018)... ... , ... The University City Science Center announced today that ... October 1, 2018. , Mr. Zarrilli brings 35 years of experience from ... management and governance levels. With a proven record in strategy, organizational growth, business ...
Breaking Biology News(10 mins):
(Date:8/9/2018)... ... ... Since their establishment in 2012, ambitions have been high at Nicoya Lifesciences. As ... last year, the company is thrilled to announce the release of their new OpenSPR ... private product launch event during the annual Protein Society Symposium in Boston on July ...
(Date:8/7/2018)... (PRWEB) , ... August 06, 2018 , ... PetPace ... a leader in pet genetic testing, today announced the launch of a groundbreaking study ... an extension of another ongoing general study of pregnant dogs sponsored by PetPace and ...
(Date:7/27/2018)... ... July 27, 2018 , ... ... and representatives of the Biotechnology Innovation Organization (BIO) met with U.S. Environmental ... “Proposal for a Toxic Substances Control Act (TSCA) Inventory Representation and Equivalency ...
(Date:7/25/2018)... ... July 25, 2018 , ... We are pleased to announce ... (FCNY) acquisition of several Erchonia low-level lasers, including both Lunula Lasers and FX ... experience. Their students receive comprehensive academic training and directly-supervised clinical experiences that ...
Breaking Biology Technology: